Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04042025 |
Recruitment Status :
Active, not recruiting
First Posted : August 1, 2019
Last Update Posted : February 22, 2024
|
Sponsor:
Novartis Gene Therapies
Information provided by (Responsible Party):
Novartis ( Novartis Gene Therapies )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | December 31, 2035 |
Estimated Study Completion Date : | December 31, 2035 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):